SLIDE 1 Forensic microbiology: whodunnit?
Corné HW Klaassen
- Dept. Medical Microbiology & Infectious Diseases
SLIDE 2 Core activities MMIZ molecular diagnostics
- Detection
- Identification,
- Typing of potentially pathogenic micro-organisms
- Bacteria, fungi/yeasts, parasites
using molecular (DNA/RNA) based techniques
SLIDE 3 Typing: a working definition
- The ability to discriminate between different ‘individuals’ of the same
species
- Not to confuse with ‘identification’: to determine to which species a
micro-organism belongs.
Shoot! A hole in my shoe! Damn! Now your footprint will discrminate you from the rest of us!
SLIDE 4 Micro-organisms are easily spread
- person to person contact!
- surfaces, air, water
- animals
- (medical) devices (e.g. humidifiers, sterilization equipment)
- food, drinks
- contact lens fluids
- etc.
SLIDE 5 Rationale for typing
Clonal expansion or different ‘individuals’ of the same species?
- Essential in potential outbreak scenario’s!
- HAI impose a significant economical burden!
- Efficacy of treatment / recurring infections?
- Monitoring local, national or global spread of specific ‘clones’
SLIDE 6 Molecular fingerprinting methods
- ‘Old’ school (not in use anymore):
- MLEE (multilocus enzyme electrophoresis)
- PFGE (pulsed field gelelectrophoresis)
- RAPD (random amplified polymorphic DNA)
- AP-PCR (arbitrarily primed PCR)
- ‘New’ school:
- AFLP (amplified fragment length electrophoresis)
- VNTR (variable number of tandem repeats)
- Microsatellites / Short tandem repeats
- MLVA (multilocus VNTR analysis)
- MLST (multilocus sequence typing)
- WGS (whole genome sequencing)
SLIDE 7 Basic characteristics of typing methods
- discriminatory power
- typeability
- reproducibility
- speed
- costs
- ease of use
- data interpretation, complexity
- need for a (pure) culture, application directly on clinical specimens
- genome coverage
- species specific vs. generic
- storage and exchange of data between labs
SLIDE 8
Amplified Fragment Length Polymorphism)
SLIDE 9
AFLP example: Aspergillus fumigatus
No prior sequence information neccessary!
SLIDE 10
Multilocus sequence typing: MLST
SLIDE 11
Multilocus sequence typing: MLST
Usually 7 markers are used
SLIDE 12
MLST for S. aureus
Ruimy et al. JB, 2008
SLIDE 13
Microsatellites: principle
SLIDE 14
Microsatellites: multiplex option
SLIDE 15
MLVA / VNTR / microsatellites
Schouls et al., PLoS One, 2009
SLIDE 16
Whole genome / Next generation sequencing:
De Been et al. JCM, 2015
SLIDE 17 Whole genome / Next generation sequencing:
- Provides superior resolution compared to any other available
genotyping method
- The ultimate genotyping / identification / characterization tool (???)
- Currently still too expensive and slow for routine use
- Different challenges with respect to data analysis and interpretation
- With a whole genome, you already have all answers, the questions will
come later ….
SLIDE 18
Hospital acquired infection?
Acinetobacter baumannii Acinetobacter baumannii
Hey neighbour: what appears to be your problem? Don’t know: same as yours?
SLIDE 19 Hospital acquired infection?
Acinetobacter baumannii Acinetobacter baumannii AFLP: indistinguishable genomes Possible transmission
to same source
SLIDE 20
Hospital acquired infection?
Enterococcus faecium Vancomycin R Enterococcus faecium Vancomycin R
Hey neighbour: what appears to be your problem? Don’t know: same as yours?
SLIDE 21
Hospital acquired infection?
Enterococcus faecium Vancomycin R Enterococcus faecium Vancomycin R MLST: indistinguishable genomes but …
SLIDE 22
Hospital acquired infection?
Enterococcus faecium Vancomycin R Enterococcus faecium Vancomycin R Strain carries ‘vanA’ gene Strain carries ‘vanB’ gene No transmission!
SLIDE 23
Hospital acquired infection?
Klebsiella pneumoniae ESBL blaCTX-M pos Klebsiella pneumoniae ESBL blaCTX-M pos
Hey neighbour: what appears to be your problem? Don’t know: same as yours?
SLIDE 24
Hospital acquired infection?
Klebsiella pneumoniae ESBL blaCTX-M pos Klebsiella pneumoniae ESBL blaCTX-M pos Strain carries ‘CTX-M-2 gene Strain carries ‘CTX-M-15’ gene No transmission! Sanger sequencing:
SLIDE 25
Hospital acquired infection?
Pseudomonas aeruginosa carbapenemase R (blaVIM-2) Pseudomonas aeruginosa carbapenemase R (blaVIM-2)
Hey neighbour: what appears to be your problem? Don’t know: same as yours?
SLIDE 26 Hospital acquired infection?
Pseudomonas aeruginosa carbapenemase R (blaVIM-2) Pseudomonas aeruginosa carbapenemase R (blaVIM-2) blaVIM-2
blaVIM-2
No transmission!
SLIDE 27 Hospital acquired infection?
Pseudomonas putida carbapenemase R (blaVIM-2) Pseudomonas aeruginosa carbapenemase R (blaVIM-2) blaVIM-2
blaVIM-2
Possible transmission
More likely to occur in the environment than between patients
SLIDE 28
- Parameters used to reveal possible transmission of potentially
dangerous micro-organisms may include analysis of the
- Genomic background (chromosome)
- Mobile elements (plasmids, integrons etc.)
- Individual genes (usually resistance genes)
…. using a wide variety of molecular methods